403 related articles for article (PubMed ID: 21198664)
1. Immunization delivered by lentiviral vectors for cancer and infectious diseases.
Hu B; Tai A; Wang P
Immunol Rev; 2011 Jan; 239(1):45-61. PubMed ID: 21198664
[TBL] [Abstract][Full Text] [Related]
2. Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.
Ciré S; Da Rocha S; Yao R; Fisson S; Buchholz CJ; Collins MK; Galy A
PLoS One; 2014; 9(7):e101644. PubMed ID: 25058148
[TBL] [Abstract][Full Text] [Related]
3. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors for anti-tumor immunotherapy.
Breckpot K; Emeagi PU; Thielemans K
Curr Gene Ther; 2008 Dec; 8(6):438-48. PubMed ID: 19075627
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
[TBL] [Abstract][Full Text] [Related]
6. Toward integrase defective lentiviral vectors for genetic immunization.
Negri DR; Michelini Z; Cara A
Curr HIV Res; 2010 Jun; 8(4):274-81. PubMed ID: 20353396
[TBL] [Abstract][Full Text] [Related]
7. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
He Y; Zhang J; Mi Z; Robbins P; Falo LD
J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
[TBL] [Abstract][Full Text] [Related]
8. Viral vectors for gene transfer into antigen presenting cells.
Monahan SJ; Salgaller ML
Curr Opin Mol Ther; 1999 Oct; 1(5):558-64. PubMed ID: 11249662
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.
Lizée G; Gonzales MI; Topalian SL
Hum Gene Ther; 2004 Apr; 15(4):393-404. PubMed ID: 15053864
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection.
Norton TD; Tada T; Leibowitz R; van der Heide V; Homann D; Landau NR
Mol Ther; 2020 Aug; 28(8):1795-1805. PubMed ID: 32497512
[TBL] [Abstract][Full Text] [Related]
11. Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine.
Coutant F; Frenkiel MP; Despres P; Charneau P
PLoS One; 2008; 3(12):e3973. PubMed ID: 19096527
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
Bryson PD; Han X; Truong N; Wang P
Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity.
Cervantes-Barragan L; Züst R; Maier R; Sierro S; Janda J; Levy F; Speiser D; Romero P; Rohrlich PS; Ludewig B; Thiel V
mBio; 2010 Sep; 1(4):. PubMed ID: 20844609
[TBL] [Abstract][Full Text] [Related]
14. New viral vectors for infectious diseases and cancer.
Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy: development of immunostimulatory treatments for cancer.
Gilligan MG; Knox PG; Searle PF
Biotechnol Genet Eng Rev; 2000; 17():497-529. PubMed ID: 11255679
[No Abstract] [Full Text] [Related]
16. Immunostimulatory DNA sequences and cancer therapy.
Weiner GJ
Springer Semin Immunopathol; 2000; 22(1-2):107-16. PubMed ID: 10944805
[No Abstract] [Full Text] [Related]
17. Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells.
Gennari F; Lopes L; Verhoeyen E; Marasco W; Collins MK
Hum Gene Ther; 2009 Jun; 20(6):554-62. PubMed ID: 19260768
[TBL] [Abstract][Full Text] [Related]
18. [Do dendritic cells modified with retroviral vectors carrying cytokine genes become a therapeutic tool?].
Szyda A; Rossowska J; Pajtasz-Piasecka E; Duś D
Postepy Hig Med Dosw (Online); 2006; 60():552-62. PubMed ID: 17115005
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
Breckpot K; Aerts JL; Thielemans K
Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
[TBL] [Abstract][Full Text] [Related]
20. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
